Conference
Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues
Abstract
PURPOSE: To review the health-related quality of life (QOL) of women treated with adjuvant hormonal therapy.
EXPERIMENTAL DESIGN: To review the limited QOL data from randomized trials of tamoxifen versus placebo and ovarian ablation versus none. To discuss QOL results from randomized trials of aromatase inhibitors compared with tamoxifen or placebo for adjuvant therapy of postmenopausal women with estrogen receptor-positive and/or progesterone …
Authors
Whelan TJ; Pritchard KI
Volume
12
Pagination
pp. 1056s-1060s
Publisher
American Association for Cancer Research (AACR)
Publication Date
February 1, 2006
DOI
10.1158/1078-0432.ccr-05-2185
Conference proceedings
Clinical Cancer Research
Issue
3
ISSN
1078-0432